LIFE : Summary for aTyr Pharma, Inc. - Yahoo Finance

U.S. Markets closed

aTyr Pharma, Inc. (LIFE)


NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
3.60+0.05 (+1.41%)
At close: 4:00 PM EST
People also watch:
QGENILMNPKIXRAYNWSA
Interactive chart
  • 1d
  • 5d
  • 1m
  • 6m
  • YTD
  • 1y
  • 2y
  • 5y
  • 10y
  • Max
1d
Previous Close3.55
Open3.60
Bid2.80 x 200
Ask3.80 x 100
Day's Range3.50 - 3.69
52 Week Range2.48 - 10.93
Volume138,782
Avg. Volume122,214
Market Cap85.39M
BetaN/A
PE Ratio (TTM)-1.38
EPS (TTM)N/A
Earnings DateN/A
Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Trade prices are not sourced from all markets
  • PR Newswireyesterday

    aTyr Pharma to Present at the BMO Prescriptions for Success Healthcare Conference

    SAN DIEGO, Dec. 9, 2016 /PRNewswire/ -- aTyr Pharma, Inc. (Nasdaq: LIFE), a biotherapeutics company engaged in the discovery and development of Physiocrine-based therapeutics to address severe, rare diseases, ...

  • aTyr Pharma, Inc. :LIFE-US: Earnings Analysis: Q3, 2016 By the Numbers : December 5, 2016
    Capital Cube5 days ago

    aTyr Pharma, Inc. :LIFE-US: Earnings Analysis: Q3, 2016 By the Numbers : December 5, 2016

    Categories: Yahoo Finance Get free summary analysis aTyr Pharma, Inc. reports financial results for the quarter ended September 30, 2016. Analysis Summary numbers: Revenues of USD 0 million, Net Earnings of USD -13.82 million. The company did not record any revenues for the last twelve months making the comparison of net margin versus asset turnover meaningless. LIFE-US‘s earnings ... Read more (Read more...)

  • PR Newswire19 days ago

    aTyr Pharma Enters into $20 Million Credit Facility

    "We believe that managing our cost of capital and creating funding opportunities with premier partners enables us to create more value for our stockholders and deliver on our promise to patients," said John Mendlein, PhD, Chief Executive Officer of aTyr Pharma. "This funding agreement allows us to build upon our long-standing relationship with and provide additional financial support to aTyr Pharma's research and clinical development initiatives," said Anthony Flores, Director for Silicon Valley Bank.